Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PACLITAXEL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2050 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Simona Ravera; Lorenzo G. Mantovani
      Valutazione dei costi associati alla terapia con taxani nel trattamento adiuvante del carcinoma della mammella in Italia

      Farmeconomia e percorsi terapeutici
    2. Wang, CG; Wu, JY; Mei, XG
      Enhanced taxol production and release in Taxus chinensis cell suspension cultures with selected organic solvents and sucrose feeding

      BIOTECHNOLOGY PROGRESS
    3. Szebeni, J; Alving, CR; Savay, S; Barenholz, Y; Priev, A; Danino, D; Talmon, Y
      Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions

      INTERNATIONAL IMMUNOPHARMACOLOGY
    4. Buchholz, TA; Hill, BS; Tucker, SL; Frye, DK; Kuerer, HM; Buzdar, AU; McNeese, MD; Singletary, SE; Ueno, NT; Pusztai, L; Valero, V; Hortobagyi, GN
      Factors predictive of outcome in patients with breast cancer refractory toneoadjuvant chemotherapy

      CANCER JOURNAL
    5. Gately, S; Kerbel, R
      Antiangiogenic scheduling of lower dose cancer chemotherapy

      CANCER JOURNAL
    6. Schink, JC; Weller, E; Harris, LS; Cella, D; Gerstner, J; Falkson, C; Wadler, S
      Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: An Eastern Cooperative Oncology Group phase II study (E2E93)

      CANCER JOURNAL
    7. Polomano, RC; Bennett, GJ
      Chemotherapy-evoked painful peripheral neuropathy

      PAIN MEDICINE
    8. Seidman, MA; Hogan, SM; Wendland, RL; Worgall, S; Crystal, RG; Leopold, PL
      Variation in adenovirus receptor expression and adenovirus vector-mediatedtransgene expression at defined stages of the cell cycle

      MOLECULAR THERAPY
    9. Smith, AB; LaMarche, MJ; Falcone-Hindley, M
      Solution structure of (+)-discodermolide

      ORGANIC LETTERS
    10. Zellweger, T; Miyake, H; July, LV; Akbari, M; Kiyama, S; Gleave, ME
      Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin

      NEOPLASIA
    11. Oberhoff, M; Herdeg, C; Al Ghobainy, R; Cetin, S; Kuttner, A; Horch, B; Baumbach, A; Karsch, KR
      Local delivery of paclitaxel using the double-balloon perfusion catheter before stenting in the porcine coronary artery

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    12. Heldman, AW; Brinker, JA
      The messenger and the message: Preventing restenosis

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    13. Makin, G; Dive, C
      Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?

      BREAST CANCER RESEARCH
    14. Johnston, SRD; Kaye, S
      Caelyx: treatment for relapsing ovarian cancer

      HOSPITAL MEDICINE
    15. Sinha, SC; Sun, J; Wartmann, M; Lerner, RA
      Synthesis of epothilone analogues by antibody-catalyzed resolution of thiazole aldol synthons on a multigram scale. Biological consequences of C-13 alkylation of epothilones

      CHEMBIOCHEM
    16. Nicolaou, KC; Namoto, K; Li, J; Ritzen, A; Ulven, T; Shoji, M; Zaharevitz, D; Gussio, R; Sackett, DL; Ward, RD; Hensler, A; Fojo, T; Giannakakou, P
      Synthesis and biological evaluation of 12,13-cyclopropyl and 12,13-cyclobutyl epothilones

      CHEMBIOCHEM
    17. Bardelmeijer, HA; Ouwehand, M; Beijnen, JH; Schellens, JHM; van Tellingen, O
      Determination of cyclosporin A in human and mouse plasma by reversed-phasehigh-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    18. Ciccolini, J; Catalin, J; Blachon, MF; Durand, A
      Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction

      JOURNAL OF CHROMATOGRAPHY B
    19. Fujino, H; Yamada, I; Shimada, S; Yoneda, M
      Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay - inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase

      JOURNAL OF CHROMATOGRAPHY B
    20. Gueritte, F
      General and recent aspects of the chemistry and structure-activity relationships of taxoids

      CURRENT PHARMACEUTICAL DESIGN
    21. Bissery, MC
      Preclinical evaluation of new taxoids

      CURRENT PHARMACEUTICAL DESIGN
    22. Stachel, SJ; Biswas, K; Danishefsky, SJ
      The epothilones, eleutherobins, and related types of molecules

      CURRENT PHARMACEUTICAL DESIGN
    23. Dong, HD; Zhong, JJ
      Significant improvement of taxane production in suspension cultures of Taxus chinensis by combining elicitation with sucrose feed

      BIOCHEMICAL ENGINEERING JOURNAL
    24. Cabral, F
      Factors determining cellular mechanisms of resistance to antimitotic drugs

      DRUG RESISTANCE UPDATES
    25. Altmann, KH
      Microtubule-stabilizing agents: a growing class of important anticancer drugs

      CURRENT OPINION IN CHEMICAL BIOLOGY
    26. Kingston, DGI
      Taxol, a molecule for all seasons

      CHEMICAL COMMUNICATIONS
    27. He, LF; Orr, GA; Horwitz, SB
      Novel molecules that interact with microtubules and have functional activity similar to Taxol (TM)

      DRUG DISCOVERY TODAY
    28. Kosmas, C; Tsavaris, NB; Vadiaka, M; Chiras, T; Boletis, J; Kostakis, A
      Extragonadal seminoma after renal transplantation and immunosuppression; Treatment in the presence of renal dysfunction - A case report and literature review

      MEDICAL ONCOLOGY
    29. Liistro, F; Colombo, A
      Late acute thrombosis after paclitaxel eluting stent implantation

      HEART
    30. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    31. Tester, W; Mora, J
      Innovative treatments for advanced non-small cell lung cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    32. Wadler, S
      New developments in the treatment of ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    33. Florsheimer, A; Altmann, KH
      Epothilones and their analogues - a new class of promising microtubule inhibitors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    34. Tenev, T; Marani, M; McNeish, I; Lemoine, NR
      Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasomeinhibitors

      CELL DEATH AND DIFFERENTIATION
    35. Schuette, W; Bork, I; Wollschlager, B; Schadlich, S
      Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer

      CLINICAL DRUG INVESTIGATION
    36. Brown, RE; Hutton, J; Burrell, A
      Cost effectiveness of treatment options in advanced breast cancer in the UK

      PHARMACOECONOMICS
    37. Plosker, GL; Hurst, M
      Paclitaxel - A pharmacoeconomic review of its use in non-small cell lung cancer

      PHARMACOECONOMICS
    38. Nanni, L; Palomba, G; Morelli, F; Piano, A; Simeone, A; D'Alessandro, V; Sirotova, Z; Capuano, G; Rinaldi, B; Lelli, G
      Combination of paclitaxel and etoposide in the treatment of advanced non-small cell lung cancer: A phase I-II study

      JOURNAL OF CHEMOTHERAPY
    39. Noujaim, AA; Schultes, BC; Baum, RP; Madiyalakan, R
      Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13 - Evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    40. Nicoletti, MI; Valoti, G; Giannakakou, P; Zhan, ZR; Kim, JH; Lucchini, V; Landoni, F; Mayo, JG; Giavazzi, R; Fojo, T
      Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-anticancer drug screen: Correlation with sensitivity to microtubule active agents

      CLINICAL CANCER RESEARCH
    41. Hata, K; Fujiwaki, R; Nakayama, K; Miyazaki, K
      Expression of the Endostatin gene in epithelial ovarian cancer

      CLINICAL CANCER RESEARCH
    42. Tortora, G; Caputo, R; Damiano, V; Bianco, R; Fontanini, G; Cuccato, S; De Placido, S; Bianco, AR; Ciardiello, F
      Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis

      CLINICAL CANCER RESEARCH
    43. Guilbaud, N; Kraus-Berthier, L; Meyer-Losic, F; Malivet, V; Chacun, C; Jan, M; Tillequin, F; Michel, S; Koch, M; Pfeiffer, B; Atassi, G; Hickman, J; Pierre, A
      Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors

      CLINICAL CANCER RESEARCH
    44. Rose, WC; Long, BH; Fairchild, CR; Lee, FYF; Kadow, JF
      Preclinical pharmacology of BMS-275183, an orally active taxane

      CLINICAL CANCER RESEARCH
    45. Modesitt, SC; Ramirez, P; Zu, ZF; Bodurka-Bevers, D; Gershenson, D; Wolf, JK
      In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer - See The Biology Behind: M. E. Murphy, the battle between tumor suppressors: Is gene therapy using p16(INK4a) more efficacious than p53 for treatment of ovarian carcinoma? Clin. Cancer Res., 7: 1487-1489, 2001.

      CLINICAL CANCER RESEARCH
    46. Alberts, DS; Hallum, AV; Stratton-Custis, M; Garcia, DJ; Gleason-Guzman, M; Salmon, SE; Santabarbara, P; Niesor, EJ; Floret, S; Bentzen, CL
      Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug

      CLINICAL CANCER RESEARCH
    47. Maliepaard, M; van Gastelen, MA; Tohgo, A; Hausheer, FH; van Waardenburg, RCAM; de Jong, LA; Pluim, D; Beijnen, JH; Schellens, JHM
      Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918

      CLINICAL CANCER RESEARCH
    48. Fujimoto-Ouchi, K; Tanaka, Y; Tominaga, T
      Schedule dependency of antitumor activity in combination therapy with capecitabine/5 '-deoxy-5-fluorouridine and docetaxel in breast cancer models

      CLINICAL CANCER RESEARCH
    49. Hurwitz, CA; Strauss, LC; Kepner, J; Kretschmar, C; Harris, MB; Friedman, H; Kun, L; Kadota, R
      Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: A pediatric oncology phase II study

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    50. Martello, LA; LaMarche, MJ; He, LF; Beauchamp, TJ; Smith, AB; Horwitz, SB
      The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies

      CHEMISTRY & BIOLOGY
    51. Wanebo, H; Chougule, P; Ready, N; Safran, H; Ackerley, W; Koness, RJ; McRae, R; Nigri, P; Leone, L; Radie-Keane, K; Reiss, P; Kennedy, T
      Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer ofthe head and neck (stage III and IV)

      ANNALS OF SURGICAL ONCOLOGY
    52. Kintzel, PE
      Prophylaxis for paclitaxel hypersensitivity reactions

      ANNALS OF PHARMACOTHERAPY
    53. Signore, PE; Machan, LS; Jackson, JK; Burt, H; Bromley, P; Wilson, JE; McManus, BM
      Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    54. Wu, CH; Yang, CH; Lee, JN; Hsu, SC; Tsai, EM
      Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    55. Ota, S; Sugiyama, T; Ushijima, K; Fujiyoshi, K; Komai, K; Hirai, N; Nishida, T; Kamura, T
      Remission of metastatic cervical adenocarcinoma with weekly paclitaxel

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    56. Vermorken, JB
      The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    57. Luck, HJ; Du Bois, A; Weber, B; Pfisterer, J; Goupil, A; Kuhn, W; Barats, JC; Blohmer, J; Mousseau, M; Schroder, W; Meier, W; Mobus, V; Richter, B
      The integration of anthracyclines in the treatment of advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    58. Bookman, MA
      Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    59. Hager, ED; Dziambor, H; Hohmann, D; Muhe, N; Strama, H
      Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    60. Pujade-Lauraine, E; Cure, H; Battista, C; Guastalla, JP; Chiurazzi, B; Fabbro, M; Tubiana-Mathieu, N; Bourgeois, H; Lioure, B; Paraiso, D; Lotz, JP
      High dose chemotherapy in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    61. Vermorken, JB
      Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    62. Poveda, A
      Remarks and conclusions on ovarian cancer treatment

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    63. Zaks-Zilberman, M; Zaks, TZ; Vogel, SN
      Induction of proinflammatory and chemokine genes by lipopolysaccharide andpaclitaxel (Taxol (TM)) in murine and human breast cancer cell lines

      CYTOKINE
    64. Gaspar, LE
      Optimizing chemoradiation therapy approaches to unresectable stage III non-small cell lung cancer

      CURRENT OPINION IN ONCOLOGY
    65. Markman, M
      Intraperitoneal chemotherapy is appropriate first line therapy for patients with optimally debulked ovarian cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    66. Calderoni, A; Cerny, T
      Taxanes in lung cancer: a review with focus on the European experience

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    67. Choy, H
      Taxanes in combined modality therapy for solid tumors

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    68. Chiara, S; Lionetto, R; Vincenti, M; Bruzzone, M; Nobile, MT; Gadducci, A; Carnino, F; Rosso, R; Conte, P
      Advanced ovarian cancer in the elderly: results of consecutive trials withcisplatin-based chemotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    69. Ichimura, T; Ishiko, O; Nishimura, S; Kojima, T; Shimura, K
      Primary peritoneal clear cell carcinoma: Excellent results from paclitaxeland carboplatin combination chemotherapy

      ONCOLOGY REPORTS
    70. Bache, M; Oehlmann, S; Meye, A; Bartel, F; Kappler, M; Wurl, P; Schmidt, H; Rath, FW; Dunst, J; Taubert, H
      Radiosensitization in sarcoma cell lines with a p53 missense mutation correlates with prevention of irradiation G2/M arrest but not with induction ofapoptosis

      ONCOLOGY REPORTS
    71. Kim, R; Osaki, A; Toge, T
      Pharmacokinetic and biochemical analysis in the treatment of weekly paclitaxel in relapsed breast cancer

      ONCOLOGY REPORTS
    72. Oyaizu, H; Adachi, Y; Okumura, T; Okigaki, M; Oyaizu, N; Taketani, S; Ikebukuro, K; Fukuhara, S; Ikehara, S
      Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lungadenocarcinoma cell line

      ONCOLOGY REPORTS
    73. Kim, R; Osaki, A; Tanabe, K; Kojima, J; Toge, T
      A phase II trial of mitomycin C, 5 '-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action

      ONCOLOGY REPORTS
    74. Adachi, S; Ogasawara, T; Ito, K; Koyama, M; Nagano, T; Suzuki, A; Yamada, T; Nakata, Y; Ozawa, M
      A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer

      ONCOLOGY REPORTS
    75. Mason, K; Staab, A; Hunter, N; McBride, W; Petersen, S; Terry, N; Milas, L
      Enhancement of tumor radioresponse by docetaxel: Involvement of immune system

      INTERNATIONAL JOURNAL OF ONCOLOGY
    76. Zagozdzon, R; Golab, J
      Immunomodulation by anticancer chemotherapy: More is not always better (review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    77. Xue, J; Cao, CY; Chen, JM; Bu, HS; Wu, HM
      A large scale separation of taxanes from the bark extract of Taxus yunnanesis and H-1- and C-13-NMR assignments for 7-epi-10-deacetyltaxol

      CHINESE JOURNAL OF CHEMISTRY
    78. Yarnold, J
      Radiation in the context of multidisciplinary approaches: radiotherapy andlocally advanced breast cancer

      BREAST
    79. Davidson, NE; Wolff, AC
      The use of anthracyclines and taxanes for adjuvant therapy of breast cancer

      BREAST
    80. Iimura, S; Uoto, K; Ohsuki, S; Chiba, J; Yoshino, T; Iwahana, M; Jimbo, T; Terasawa, H; Soga, T
      Orally active docetaxel analogue: Synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    81. Dai, D; Zeldin, DC; Blaisdell, JA; Chanas, B; Coulter, SJ; Ghanayem, BI; Goldstein, JA
      Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid

      PHARMACOGENETICS
    82. Kosmas, C; Tsavaris, N; Panopoulos, C; Vadiaka, M; Stavroyianni, N; Kourelis, T; Malamos, N; Antonopoulos, M; Kalofonos, HP
      Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens

      EUROPEAN JOURNAL OF CANCER
    83. Liang, Y; Meleady, P; Cleary, I; McDonnell, S; Connolly, L; Clynes, M
      Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness

      EUROPEAN JOURNAL OF CANCER
    84. Laack, E; Mende, T; Benk, J; Chemaissani, A; Scholtze, J; Lorenz, C; Niestroy, A; Dalhoff, K; Muller, T; Walter, T; Durk, H; Edler, L; Hossfeld, DK
      Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

      EUROPEAN JOURNAL OF CANCER
    85. De Lena, M; Lorusso, V; Latorre, A; Fanizza, G; Gargano, G; Caporusso, L; Guida, M; Catino, A; Crucitta, E; Sambiasi, D; Mazzei, A
      Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

      EUROPEAN JOURNAL OF CANCER
    86. Menendez, JA; Barbacid, MD; Montero, S; Sevilla, E; Escrich, E; Solanas, M; Cortes-Funes, H; Colomer, R
      Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells

      EUROPEAN JOURNAL OF CANCER
    87. Antman, KH
      A critique of the eleven randomised trials of high-dose chemotherapy for breast cancer

      EUROPEAN JOURNAL OF CANCER
    88. Smorenburg, CH; Sparreboom, A; Bontenbal, M; Verweij, J
      Combination chemotherapy of the taxanes and antimetabolites: its use and limitations

      EUROPEAN JOURNAL OF CANCER
    89. Gelderblom, H; Verweij, J; Nooter, K; Sparreboom, A
      Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

      EUROPEAN JOURNAL OF CANCER
    90. Cull, A; Howat, S; Greimel, E; Waldenstrom, AC; Arraras, J; Kudelka, A; Chauvenet, L; Gould, A
      Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report

      EUROPEAN JOURNAL OF CANCER
    91. Garattini, S; La Vecchia, C
      Perspectives in cancer chemotherapy

      EUROPEAN JOURNAL OF CANCER
    92. Underhill, CR; Parnis, FX; Highley, MS; Ahern, J; Harper, PG; Hansen, H; Lund, B; Dombernowsky, P; Hirsch, F; Hansen, M; Carmichael, J; Williams, C
      Multicenter phase II study of gemcitabine in previously untreated patientswith advanced epithelial ovarian cancer

      ANTI-CANCER DRUGS
    93. Malingre, MM; Huinink, WWT; Duchin, K; Schellens, JHM; Beijnen, JH
      Pharmacokinetics of oral cyclosporin A when co-administered to enhance theoral absorption of paclitaxel

      ANTI-CANCER DRUGS
    94. Waltmire, CN; Alberts, DS; Dorr, RT
      Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer

      ANTI-CANCER DRUGS
    95. Hirashima, Y; Kobayashi, H; Nishiguchi, T; Miura, K; Kanayama, N
      A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin

      ANTI-CANCER DRUGS
    96. Kikuchi, Y; Hiramatsu, H; Seto, H; Kita, T
      A rare case of advanced ovarian carcinoma who developed difficulty walking25 days after treatment with weekly paclitaxel

      ANTI-CANCER DRUGS
    97. Li, N; van Agthoven, M; Willemse, PHB; Uyl-de Groot, CA
      A cost-utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer

      ANTI-CANCER DRUGS
    98. Tomita, M; Kurata, H; Aoki, Y; Tanaka, K; Kazama, JJ
      Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancer

      ANTI-CANCER DRUGS
    99. Seligson, AL; Terry, RC; Bressi, JC; Douglass, JG; Sovak, M
      A new prodrug of paclitaxel: synthesis of Protaxel

      ANTI-CANCER DRUGS
    100. Terwogt, JMM; Huinink, WWT; Schellens, JHM; Schot, M; Mandjes, IAM; Zurlo, MG; Rocchetti, M; Rosing, H; Koopman, FJ; Beijnen, JH
      Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel

      ANTI-CANCER DRUGS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 17:41:40